#HVO hVIVO PLC – Issue of Equity and Total Voting Rights February 23, 2026 – Posted in: hVIVO (HVO)
London, UK – 23 February 2026, hVIVO plc (AIM: HVO), a full-service early phase Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces the issue of 1,386,991 new Ordinary Shares of £0.001 each in the Company (“First Consideration Shares”) to three managers of Cryo-Store Limited (“Cryostore”). This issuance comprises the first tranche (50%) of the equity consideration payable pursuant to the acquisition of Cryostore announced on 27 February 2025 (the “Acquisition”). …
Continue reading